期刊文献+

经典型枫糖尿症1例随访18个月报告 被引量:3

A report of 18-month follow-up study on a case of classic maple syrup urine disease
暂未订购
导出
摘要 目的探讨经典型枫糖尿症的远期预后及治疗,尤其是饮食治疗。方法随访1例经典型枫糖尿症患儿,重点观察其新生儿期后并发症的发生及饮食情况。结果患儿遗留明显的神经系统损害,但在新生儿期后,以亮氨酸日耐受量为核心控制目标的个性化饮食治疗有效减少了代谢危象及并发症的发生。患儿致病基因位于BCKDHB。结论监测支链氨基酸和个性化饮食治疗有助于减少枫糖尿症患儿急性代谢危象及并发症的发生,提高其生存质量。 Objectives To explore the long-term prognosis, treatment (especially dietary treatment) of classic maple syrup urine disease. Methods The complications and dietary treatment were observed by follow-up study of a classic MSUD patient. Results The patient have obvious damage in nervous system. However, reasonable dietary leucine tolerance therapy after the neonatal period can effectively reduce the metabolic crisis and complications. A mutation in BCKDHB gene was detected in the patient by genetic testing. Conclusion It is suggested that dietary restriction and monitoring of branched-chain amino acids are helpful to reduce the development of acute metabolic crisis and complications and improve the quality of life.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2013年第10期968-971,共4页 Journal of Clinical Pediatrics
关键词 枫糖尿症 并发症 治疗 基因型 临床表型 maple syrup urine disease complications therapy genotype clinical phenotype
  • 相关文献

参考文献10

  • 1Zinnanti WJ, Lazovic J, Griffin K, et al. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease [J]. Brain, 2009,132(Pt 4): 903-918.
  • 2Zirmanti WJ, Lazovic J. Interrupting the mechanisms ofbrai injury in a model of maple syrup urine disease encephalopath [J]. J Inherit Metab Dis, 2012,35(1): 71-79.
  • 3Strauss KA, Puffenberger EG, Morton DH. Maple syrup urine disease [M]//Pagon RA, Adam MP, Bird TD, et aL GeneReviews rra [Internet]. Seattle (WA):University of Wa- shington, Seattle,2006:1993-2013.
  • 4Sowell J, Pollard L, Wood T. Quantification of branched-chain amino acids in blood spots and plasma by liquid chroma- tography tandem mass spectrometry for the diagnosis of maple syrup urine disease [J]. J Sep Sci, 2011,34(6): 631-639.
  • 5Strauss KA, Morton DH. Branched-chain ketoacyl dehydro- genase deficiency: maple syrup disease [J]. Curr Treat Options Neurol, 2003,5(4): 329-341.
  • 6Morton DH, Strauss KA, Robinson DL, et al. Diagnosis and treatment of maple syrup disease: a study of 36 patients [J]. Pediatrics, 2002,109(6): 999-1008.
  • 7Chuang DT. Maple syrup urine disease:it has come a long way [J]. J Pediatr, 1998, 132(3 Pt 2): S17-$23.
  • 8Ruch T, Kerr D. Decreased essential amino acid requirements without catabolism in phenylketonuria and maple syrup urine disease [J]. Am J Clin Nutr, 1982,35(2):217-228.
  • 9Mitsubuchi H, Owada M, Endo E Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease [J]. J Nutr,2005, 135(6 Suppl): 1565S-1570S.
  • 10Yang N, Han L, Gu X, et al. Analysis of gene mutations in Chinese patients with maple syrup urine disease [J]. Mol Genet Metab, 2012,106(4): 412-418.

同被引文献42

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部